entertainment -WSS

entertainment

author：fashion 2025-09-30 15:16:24 - browse：37767

Exterior photo of UnitedHealth Group building — UnitedHealth Group is attempting to buy Amedisys for $3.3 billion. Courtesy UnitedHealth Group

There’s now a two-party showdown for one of the largest home health companies in the country.

UnitedHealth Group and its Optum division on Monday formally proposed to buy Amedisys for $100 per share, or about $3.3 billion.

The offer comes a few weeks after Option Care Health proposed a $3.6 billion takeover. However, Option Care’s deal is an all-stock transaction, whereas UnitedHealth would pay all cash — a potentially more attractive offer for Amedisys shareholders who want a more immediate payout that isn’t tied to the unpredictability of another company’s stock price. Option Care’s offer is technically worth closer to $2.8 billion now, due to the drop in Option Care’s stock price since the merger was announced. Amedisys is recommending shareholders vote in favor of the deal with Option Care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Cue Health, Covid

focus

WSS

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

UnitedHealth argues against case alleging wrongful AI care denials

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Digital health: a case of mistaken identity

SCOTUS questions limit to govt efforts to fight misinformation

Creating egg and sperm cells from stem cells raises ethical issues

knowledge

entertainment

focus

Guidelines to prevent youth baseball injuries need more muscle

Digital health: a case of mistaken identity

In age of alternative facts, a scholarly course on calling out crap

ASCO eve: Let’s set the table for this year's meeting

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Scrutiny of post

Supreme Court strikes down use of affirmative action

Scrutiny of post

Medical records are filled with copy

Future doctors should be trained to promote social change

explore

Stop the failed accountable care organization experiment

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Colonoscopy prep: Liquid

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

For longer

Virtual Event: March of the Biosimilars

hotspot

entertainment

hotspot

entertainment